Publication | Closed Access

Comorbidity, age and overall survival in patients with advanced pancreatic cancer – Results from NCIC CTG PA.3: A phase III trial of gemcitabine plus erlotinib or placebo

Pancreatic CancerOverall SurvivalNcic Ctg Pa.3MedicineGastrointestinal OncologyPhase Iii TrialPharmacotherapyCancer TreatmentOncologyRadiation OncologyMolecular Oncology